Boralex (TSE:BLX – Get Free Report) had its price target lowered by equities researchers at Cormark from C$47.00 to C$35.00 in a research note issued on Thursday,BayStreet.CA reports. Cormark’s price objective points to a potential upside of 39.50% from the company’s current price.
A number of other equities research analysts have also weighed in on the stock. Scotiabank decreased their price objective on shares of Boralex from C$42.00 to C$36.00 and set a “sector perform” rating for the company in a report on Thursday. BMO Capital Markets decreased their price objective on shares of Boralex from C$46.00 to C$45.00 in a report on Friday, November 15th. Finally, CIBC decreased their price objective on shares of Boralex from C$42.00 to C$40.00 and set an “outperform” rating for the company in a report on Wednesday, January 8th. One equities research analyst has rated the stock with a hold rating, four have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, Boralex presently has a consensus rating of “Buy” and an average target price of C$40.88.
View Our Latest Analysis on BLX
Boralex Trading Up 1.6 %
Boralex Company Profile
Boralex Inc is an electric utility company involved in the development, construction, and operation of renewable energy power facilities. The company controls a portfolio of electricity producing plants that utilize wind, hydroelectric, thermal, and solar fuel sources. Most of Boralex’s plants rely on wind power, while a significant number also employ hydroelectric power.
Read More
- Five stocks we like better than Boralex
- What Are Dividend Champions? How to Invest in the Champions
- DeepSeek Dip: Is the Nuclear Energy Sell-Off a Buying Opportunity
- What is the Dogs of the Dow Strategy? Overview and Examples
- ASML: Strengths and Upside Remain Despite DeepSeek Worries
- High Flyers: 3 Natural Gas Stocks for March 2022
- Royal Caribbean Soars, But Smooth Sailing Isn’t Guaranteed
Receive News & Ratings for Boralex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Boralex and related companies with MarketBeat.com's FREE daily email newsletter.